[The expression of PD-L1 in the non-small cell lung cancer and the correlation with the novel lung adenocarcinoma classification]. - Suppr | 超能文献

[The expression of PD-L1 in the non-small cell lung cancer and the correlation with the novel lung adenocarcinoma classification].

作者信息

Zhang D C, Shi Y Q, Yan Z T, Gao X, Peng L, Peng Y, He W T, Li Q

机构信息

Department of Pathology, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China.

Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):607-609. doi: 10.3760/cma.j.cn112151-20191015-00561.

DOI:10.3760/cma.j.cn112151-20191015-00561

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[The expression of PD-L1 in the non-small cell lung cancer and the correlation with the novel lung adenocarcinoma classification].

Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):607-609. doi: 10.3760/cma.j.cn112151-20191015-00561.

2

Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.程序性死亡细胞配体1（PD-L1）与I期非小细胞肺癌的生存率相关。

Semin Thorac Cardiovasc Surg. 2017;29(3):408-415. doi: 10.1053/j.semtcvs.2017.05.008. Epub 2017 May 26.

3

Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.PD-L1表达及PD-L1基因多态性与肺腺癌和肺鳞癌预后不良的相关性

Hum Pathol. 2017 Oct;68:103-111. doi: 10.1016/j.humpath.2017.08.016. Epub 2017 Aug 26.

4

Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.程序性死亡配体1（PD-L1）在肿瘤细胞或肿瘤浸润免疫细胞中的表达与实性和高级别肺腺癌相关。

Arch Pathol Lab Med. 2017 Nov;141(11):1529-1532. doi: 10.5858/arpa.2017-0028-OA. Epub 2017 Aug 22.

5

Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.程序性细胞死亡配体1（PD-L1）、CD8 +肿瘤浸润淋巴细胞和p53在非小细胞肺癌中的预后意义：一项免疫组织化学研究

Turk Patoloji Derg. 2017;1(1):211-222. doi: 10.5146/tjpath.2017.01398.

6

Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma.程序性死亡配体1表达可预测表皮生长因子受体突变阳性肺腺癌患者队列中酪氨酸激酶抑制剂的反应及更好的预后。

Clin Lung Cancer. 2015 Sep;16(5):e25-35. doi: 10.1016/j.cllc.2015.02.002. Epub 2015 Feb 19.

7

Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients.SP263 单克隆抗体检测非小细胞肺癌患者 PD-L1 表达水平≥50%的临床意义。

Thorac Cancer. 2019 Feb;10(2):175-182. doi: 10.1111/1759-7714.12929. Epub 2018 Dec 11.

8

Prominent Nucleoli and Non-glandular Feature Are Independent Predictors of PD-L1 Expression in Lung Adenocarcinoma.显著核仁与非腺特征是肺腺癌中PD-L1表达的独立预测因素。

Anticancer Res. 2018 Oct;38(10):6003-6008. doi: 10.21873/anticanres.12949.

9

Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).表达程序性细胞死亡配体1（PD-L1）的肺癌的临床和病理特征

Lung Cancer. 2016 Aug;98:69-75. doi: 10.1016/j.lungcan.2016.04.021. Epub 2016 May 25.

10

Positive Conversion of PD-L1 Expression After Treatments with Chemotherapy and Nivolumab.化疗和纳武单抗治疗后PD-L1表达的阳性转化

Anticancer Res. 2017 Oct;37(10):5713-5717. doi: 10.21873/anticanres.12009.